Name:
Human Coagulation Factor IX
Category:
Hematology, Critical Illness
Use within:
24 months
Specifications:
500IU/vial, 10ml after redissolution
Approval number:
NMPA Approval No. S20233098
Indications:
Used for bleeding treatment in patients aged 12 and above with factor IX deficiency (hemophilia B).
Human Coagulation Factor IX is a vital glycoprotein essential for the blood clotting cascade. Produced via recombinant DNA technology or plasma fractionation, it functions as an enzyme cofactor. The molecular formula is C500+H800+N150+O120+S4+ (variable), and its CAS number is 9001-36-7.
Strictly contraindicated in patients with known hypersensitivity to murine or hamster proteins. Must be stored at 2°C–8°C away from light; do not freeze. Reconstitution requires sterile saline only. Monitor for inhibitor development and thrombotic events during infusion.